Literature DB >> 31685110

ACR Appropriateness Criteria® Stage I Breast Cancer: Initial Workup and Surveillance for Local Recurrence and Distant Metastases in Asymptomatic Women.

Alana A Lewin1, Linda Moy2, Paul Baron3, Aarati D Didwania4, Roberta M diFlorio-Alexander5, Jessica H Hayward6, Huong T Le-Petross7, Mary S Newell8, Amar Rewari9, John R Scheel10, Ashley R Stuckey11, W Warren Suh12, Gary A Ulaner13, Nina S Vincoff14, Susan P Weinstein15, Priscilla J Slanetz16.   

Abstract

As the proportion of women diagnosed with early stage breast cancer increases, the role of imaging for staging and surveillance purposes is considered. National and international guidelines discourage the use of staging imaging for asymptomatic patients newly diagnosed with stage 0 to II breast cancer, even if there is nodal involvement, as unnecessary imaging can delay care and affect outcomes. In asymptomatic patients with a history of stage I breast cancer that received treatment for curative intent, there is no role for imaging to screen for distant recurrences. However, routine surveillance with an annual mammogram is the only imaging test that should be performed to detect an in-breast recurrence or a new primary breast cancer in women with a history of stage I breast cancer. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
Copyright © 2019 American College of Radiology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AUC; Appropriate Use Criteria; Appropriateness Criteria; Breast MRI; Breast cancer; Mammography; Stage I; Ultrasound

Mesh:

Year:  2019        PMID: 31685110     DOI: 10.1016/j.jacr.2019.05.024

Source DB:  PubMed          Journal:  J Am Coll Radiol        ISSN: 1546-1440            Impact factor:   5.532


  3 in total

1.  Post-operative imaging surveillance of breast cancer patients status post lumpectomy with BioZorb implant placement.

Authors:  Shruthi Ram; Eric Dietsche
Journal:  J Radiol Case Rep       Date:  2021-02-28

2.  A Comparison of the Diagnostic Value of Positron Emission Tomography/Computed Tomography and Ultrasound for the Detection of Metastatic Axillary Nodal Disease in Treatment-Naive Breast Cancer.

Authors:  Viet T Le; Franklin C Wong; Roland L Bassett; Gary J Whitman
Journal:  Ultrasound Q       Date:  2020-11-13       Impact factor: 1.462

3.  Clinical impact of follow-up imaging on mortality in Korean breast cancer patients: A national cohort study.

Authors:  So-Youn Jung; Young Ae Kim; Dong-Eun Lee; Jungnam Joo; Joung Hwan Back; Sun-Young Kong; Eun Sook Lee
Journal:  Cancer Med       Date:  2021-09-01       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.